Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2009
11/05/2009WO2009134338A2 Early prostate cancer antigen-2: a novel serum specific marker for prostate cancer detection
11/05/2009WO2009134327A2 Methods and reagents to increase the sensitivity of enzyme metallographic detection
11/05/2009WO2009134226A1 Canine coat color prediction
11/05/2009WO2009134120A1 Mass spectrometric analysis of small molecule analytes
11/05/2009WO2009134104A2 Biosensor for detection of immunoproteins using porous silicon and a production method therefor
11/05/2009WO2009133951A1 Anti-perspiration antigen monoclonal antibody
11/05/2009WO2009133939A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009WO2009133928A1 Leukocyte analysis method and analysis reagent for use in the method
11/05/2009WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same
11/05/2009WO2009133769A1 Device for measuring blood coagulation ability
11/05/2009WO2009133696A1 Method for labelling sugar chains
11/05/2009WO2009133642A1 Method for evaluation of anti-tumor activity, and method for screening of anti-tumor substance by employing the method
11/05/2009WO2009133521A2 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders
11/05/2009WO2009133294A2 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules
11/05/2009WO2009133202A1 Set of magnetic labels
11/05/2009WO2009133192A1 Induction of aging phenotypes
11/05/2009WO2009133169A1 Method of determining alanine transaminase (alt) activity by 13c-mr detection using hyperpolarised 13c-pyruvate
11/05/2009WO2009133152A1 Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
11/05/2009WO2009133140A1 Biological method for in vivo tracking of molecules affecting cellular migration
11/05/2009WO2009133101A1 Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods
11/05/2009WO2009133088A1 PRO-EPIL EXPRESSION LEVEL IN A BIOLOGICAL SAMPLE AS TESTICULAR CANCER BIOMARKER, PARTICULARLY IN COMBINATION WITH THE HCGβ AND AFP BIOMARKERS
11/05/2009WO2009133071A2 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
11/05/2009WO2009132893A1 Method and device for determining the relative humidity of an insulating liquid filled electric apparatus
11/05/2009WO2009132857A1 Method to measure cloudiness of paints on test tables
11/05/2009WO2009132820A1 Suspension arrays for species-species interaction studies
11/05/2009WO2009132815A1 Use of sfrp-3 in the assessment of heart failure
11/05/2009WO2009132770A2 Method for calibrating measuring appliances
11/05/2009WO2009132727A1 On-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant and corresponding control method and equipment
11/05/2009WO2009132667A1 Method for verifying and/or determining the concentration of a ligand
11/05/2009WO2009132655A2 Design and use of sortilin specific molecular imaging ligands
11/05/2009WO2009132510A1 Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
11/05/2009WO2009132484A1 Lytic proteins of vero cell, preparation method thereof and detection kit for vero hcp comprising the same
11/05/2009WO2009132473A1 An inregrated on-site biosensor
11/05/2009WO2009132423A1 Acetaminophen assay
11/05/2009WO2009132397A1 Methods and agents for modulating the level and/or activity of hif-2 alpha protein
11/05/2009WO2009112692A3 Reaction cuvette supply to an automatic analysis machine
11/05/2009WO2009111372A3 Methods and devices for monitoring of frying oil quality
11/05/2009WO2009111370A3 Monitoring of frying oil quality using combined optical interrogation methods and devices
11/05/2009WO2009111067A3 Methods for the identification of agents that inhibit mesenchymal -like tumor cells or their formation
11/05/2009WO2009109809A3 Atomic force microscope as an analyzing tool for biochip
11/05/2009WO2009108911A3 Methods for characterizing foods and drinks
11/05/2009WO2009108802A3 Method for patient genotyping
11/05/2009WO2009106473A3 Non-marker chromosome screening
11/05/2009WO2009103555A3 Mucosal membrane receptor and uses thereof
11/05/2009WO2009102717A3 Screening methods for identifying target antifungal genes and compounds by detecting cell surface glycoproteins
11/05/2009WO2009100953A3 Diagnostic method
11/05/2009WO2009100447A3 Detection of degradative enzymes and biomolecules in bodily fluids
11/05/2009WO2009100327A3 Methods of diagnosing chronic prostatitis/chronic pelvic pain syndrome
11/05/2009WO2009100262A3 Oral care methods and systems
11/05/2009WO2009100243A3 Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
11/05/2009WO2009100215A3 Detection of clostridium difficile
11/05/2009WO2009099601A9 Chk1 suppresses a caspase-2 apoptotic response to dna damage that bypasses p53, bcl-2 and caspase-3
11/05/2009WO2009097425A3 Method for detecting truncated molecules
11/05/2009WO2009091187A3 Bio-disc
11/05/2009WO2009088837A3 Methods and products to target, capture and characterize stem cells
11/05/2009WO2009086411A3 Negative mimic antibody for use as a blocking reagent in bnp immunoassays
11/05/2009WO2009085196A8 Methods and compositions for correlating genetic markers with prostate cancer risk
11/05/2009WO2009076359A3 Modulators of neuronal regeneration
11/05/2009WO2009071880A3 Prognostic marker for cancer
11/05/2009WO2009063307A3 Inflammatory activity detection method using il-6
11/05/2009WO2009056340A3 Device for the detection of components in a fluid
11/05/2009WO2009054996A8 Systems and methods for viral therapy
11/05/2009WO2009007787A3 Systems and methods for biological and chemical detection, comprising automatic selection of reagent sets
11/05/2009WO2008154333A3 Mir-34 regulated genes and pathways as targets for therapeutic intervention
11/05/2009WO2008148492A8 Neurofilamental proteins as biomarker for alzheimer's disease
11/05/2009WO2008148491A8 Neural cell adhesion molecule 1 as biomarker for alzheimer's disease
11/05/2009WO2008024754A9 Nucleic acid array with releasable nucleic acid probes
11/05/2009WO2007117215A8 Binder for c-reactive protein
11/05/2009WO2004063710A9 Mark-pap system (method, kit, solution & accessories) processes for producing and using the same
11/05/2009US20090276864 Transgenic animals with reduced major urinary protein production
11/05/2009US20090276863 Protein formulations comprising s1-5
11/05/2009US20090276161 Heart age assessment
11/05/2009US20090275861 Body fluid testing device
11/05/2009US20090275738 Use of A33 antigens and jam-it
11/05/2009US20090275649 Compositions And Methods For Identifying Modulars Of TRPV2
11/05/2009US20090275644 Novel adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
11/05/2009US20090275643 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275521 Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
11/05/2009US20090275512 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation
11/05/2009US20090275499 Nonstructural protein ns1 as a novel therapeutic target against flaviviruses
11/05/2009US20090275497 Method for identifying modulators of the activity of ion-channels receptors
11/05/2009US20090275496 Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods
11/05/2009US20090275495 Methods and compositions relating to alzheimer's disease
11/05/2009US20090275480 Universal readout for target identification using biological microarrays
11/05/2009US20090275145 Metal-enhanced fluorescence for polarization-based affinity assays
11/05/2009US20090275143 Nanostructure array and methods of use for explosive detection
11/05/2009US20090275142 Compositions and methods for biodetection by nucleic acid-templated chemistry
11/05/2009US20090275141 Affinity Adsorbents for Factor VIII and Von Willebrand's Factor
11/05/2009US20090275140 Hemoglobin Based Bilirubin Reference Material
11/05/2009US20090275137 High affinity tcr proteins and methods
11/05/2009US20090275125 Human T1R2 Taste Receptor Nucleic Acids and Cells Containing These Nucleic Acids
11/05/2009US20090275124 Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
11/05/2009US20090275115 Microreactor
11/05/2009US20090275106 Polynucleotide encoding A polypeptide having heparanase activity and expression of same in genetically modified cells
11/05/2009US20090275100 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
11/05/2009US20090275079 Novel genes encoding novel proteolytic enzymes
11/05/2009US20090275069 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
11/05/2009US20090275066 Immobilization of membrane porteins onto supports via an amphiphile
11/05/2009US20090275062 Extracting tacrolimus in a non-precipitating, non-denaturing aqueous environment, eliminates use of organic solvents and centrifugation, also fulfills the requirements for full automation of tacrolimus quantification assays
1 ... 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 ... 3937